Skip to main content
Neill PF Storrar on Muck Rack

Neill PF Storrar

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Neill PF

Contact Neill PF, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity

|
By Thomas Fox, Stephen Jolles, Niall Conlon, Charu Chopra, Eleni Tholouli, Moira Thomas, Lisa Anne Devlin, Claire Stockdale, Aarnoud P Huissoon, Neill PF Storrar, Hannah Hunter, Francesca Ferrua, Olaf Neth, Adrian Shields, Sarah Goddard, Arjan Kwakernaak, Godelieve de Bree, Franziska Taube, Katja Sockel, Julia Körholz, Carmen D. Herling, Christian Klemann, Vikram Singh Verified, Veronika Dobšinská, Sarah Johnston, Samar Ojaimi, Ravishankar Sargur, Shankara Paneesha, Danielle Blunt, Shreyans Gandhi, Fredrik Rorsman, Sinisa Savic, Arpad Toth, Helen L. Leavis, Maria Carrabba, Sujoy Khan, Kiran Tawana, John A Snowden, David Lowe, Sorena Kiani-Alikhan, Ariharan Anantharachagan, Catharina Schuetz, Smita Patel, Arian Laurence, Siobhan O. Burns, Venetia Bigley, Emma Morris, Katharine Orf, Hannah Al Yousuf, Nadhira Samsudeen, Suzanne Elcombe, Mari Campbell, Jennifer M. Tjon, Tor Henrik Tvedt, Harichandana Ghanta, Elisa Codero, Anoop Mistry, Prashantha Vaitla, Carsten Schade-Larsen, Valérie Massey, Pavels Gordins, Simon Bulley, Vanessa Daza-Cajigal, Ben Uttenthal
| Nature Verified
Abstract Outcomes following international MDT assessment of adult IEI patients for allogeneic HSCT suggest early referral is vital: patients considered too high risk for transplant have poor outcomes with a 3-year overall survival of 31%.
Open in Who Shared Issue with article?

Investigating thrombocytosis

|
By Abhinav Mathur, Mark Vickers, Shehan Samaranayake, Neill PF Storrar
| bmj.com
We use cookies to improve our service and to tailor our content and advertising to you. More info Close You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our cookies policy Close Intended for healthcare professionals Toggle navigation The BMJ logo Toggle top menu Education Investigating...
Open in Who Shared Issue with article?
See all 2 articles